Rheumatoid is a difficult disease and is listed by the World Health Organization as one of the five most difficult diseases in humans, which shows how difficult it is to treat.
At present, the main purpose of medicine is to relieve joint pain, prevent joint damage, and preserve and improve joint function.
But now the formula Su Zhe has come up with can cure rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, gouty arthritis, ankylosing spondylitis, reactive arthritis, infectious arthritis, and other diseases. Dozens of inflammatory diseases such as traumatic arthritis, psoriatic arthritis, enteropathic arthritis, etc. can all be effectively treated.
And this is just one formula that can cure all arthritis. For this reason alone, none of the drugs currently on the market can do this.
Not to mention that the therapeutic effect of this formula is unprecedentedly good. It can be said that no other similar drug can compare with Su Zhe's.
Therefore, Li Changhua and Liu Xiong believe that the value of the formula Su Zhe brought now will not be lower than the blue elixir, and may even be higher.
Therefore, you can imagine how much impact this formula will have if it is successfully launched.
That¡¯s why Li Changhua and Liu Xiong were so shocked in the conference room.
The most important thing is that Su Zhe¡¯s formula has extremely low production costs and can also be mass-produced.
Currently [, ww¡é, its indications are rheumatoid arthritis, Crohn's disease, spondylitis, psoriasis, and ulcerative colitis. This is one of the 25 best-selling drugs in the world.
This is the flagship product of a foreign pharmaceutical giant. It has won the title of the world's highest-selling drug for several consecutive years. Huge profits were made for the pharmaceutical company.
This drug is an injection. A 40mg tube costs as much as 7,900 yuan, and one needs to be injected every two weeks, which costs up to 200,000 yuan a year.
If the patient's treatment effect decreases, the dosage will need to be increased to 40 mg per week to improve the effect, which will increase the cost a lot.
An injection costs 7,900 yuan. For many people, at least for many families in China, it is difficult to accept and afford the cost.
After all, the treatment is definitely not just an injection, which can cure the disease. It requires long-term treatment.
In this case, you can imagine how many people cannot afford medicine because the cost is too high. Can't cure the disease.
So, although there are many diseases. Effective treatments have been developed now, but for many people, they are still as unaffordable as before, which makes people even more desperate.
Li Changhua and Liu Xiong can imagine that if the formula Su Zhe now masters is introduced to the drug market, it will create a huge disturbance, because many drugs will be affected and affected.
¡° Moreover, the formula Su Zhe came up with does not have the side effects of similar drugs and has no treatment risks at all.
The most important thing is that the production cost of this formula is not high. Based on Su Zhe's past style, the price of this drug will definitely not be high after it is launched, and it will definitely be countless times cheaper than similar drugs.
In this way, the changes to the market will be very big.
Su Zhe only thought about how many people this formula could help, but Li Changhua and Liu Xiong thought about how much impact this formula would have on the current drug market.
¡°Try to develop this formula and then put it on the market in the shortest possible time.¡± Su Zhe said after introducing the formula to Li Changhua and Liu Xiong.
"Can we guarantee that the potion of this formula will be produced?" From Su Zhe's introduction just now, Li Changhua knew that the production of this formula also requires healing potion, so he asked this question now.
"I will solve the problem of the potion. You just need to get it on the market as soon as possible." Su Zhe replied.
The medicines currently produced by Changhua Pharmaceutical need to meet domestic and foreign demands. Based on the current output, the therapeutic potion required per month is about 120 million ml.
And this is the minimum standard, which is calculated based on the current production plan. If the production plan is increased, the number of healing potions required will be far more than this number.
However, Su Zhe refined more than 9 million ml of healing potion in a day, and at least 270 million ml in a month.
Even if we exclude the treatment potions needed by the Yadai Group, there is still a huge surplus, at least about 100 million ml.
So Su Zhe is not worried about not having treatment potions to produce new drugs.
Therefore, Su Zhe¡¯s request? The goal is to try our best to allow this new formula to successfully enter the market. The sooner it enters the market, the greater the benefits will be for many patients.
Even if Su Zhe cannot allow all patients to take this medicine, he does not have that many therapeutic potions to produce.
But Su Zhe believes that as long as this new drug enters the market, it will definitely reduce the prices of many similar drugs.
In fact, many of the best-selling drugs now are extremely expensive, although high research and development costs are part of the reason.
But the most important thing is that these best-selling drugs have no competitors, so they can sell them at the highest price and make the maximum profit.
If Changhua Pharmaceutical can bring new drugs to the market, then these best-selling drugs will have competitors.
Facing the low-price sales of Changhua Pharmaceutical, these pharmaceutical companies can only choose to cut prices to face the impact of Changhua Pharmaceutical.
This is not without examples. Since Changhua Pharmaceutical successively launched Meibiling, Xingshen Tablets, Thaws Ling, and Blue Spirit Medicine, many medicines on the market have experienced significant price cuts.
There is no way around this, because the medicines produced by Changhua Pharmaceutical not only have good therapeutic effects, but are also very cheap.
If the prices of these similar drugs are not reduced, there will be no market at all.
This is due to Changhua Pharmaceutical¡¯s production problems, which cannot meet the needs of all patients. Therefore, there is room for production of similar drugs on the market.
¡°Otherwise, the sales of the medicine produced by Changhua Pharmaceutical would have been completely cut off.
Because Changhua Pharmaceutical has a great advantage in terms of price and treatment effect, and other similar drugs do not pose a threat to Changhua Pharmaceutical at all.
Although Changhua Pharmaceutical has not yet had much impact on foreign markets.
But at least in the domestic market, Changhua Pharmaceutical has had a great impact on many similar drugs.
So as long as Changhua Pharmaceutical launches new drugs, these patients will benefit more or less. That's why Su Zhe asked Li Changhua and the others to develop this formula in the shortest possible time